Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Gilead Sciences
(NQ:
GILD
)
141.95
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Jan 30, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,832
Open
141.95
Bid (Size)
141.00 (400)
Ask (Size)
141.99 (100)
Prev. Close
141.95
Today's Range
141.95 - 141.95
52wk Range
93.37 - 142.20
Shares Outstanding
1,253,809,440
Dividend Yield
2.23%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
3 Cash-Producing Stocks with Warning Signs
January 29, 2026
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak...
Via
StockStory
The Commonwealth Club Honors Black History Month With Event Featuring Top Black Leaders in AI & Biopharma Discussing the Future of Healthcare
January 29, 2026
Via
Get News
Topics
Artificial Intelligence
Performance
YTD
+16.7%
+16.7%
1 Month
+16.7%
+16.7%
3 Month
+16.3%
+16.3%
6 Month
+24.0%
+24.0%
1 Year
+44.3%
+44.3%
More News
Read More
Are Wall Street Analysts Predicting Gilead Sciences Stock Will Climb or Sink?
January 29, 2026
Via
Barchart.com
Topics
ETFs
Gilead Sciences to Release Fourth Quarter & Full Year 2025 Financial Results on Tuesday, February 10, 2026
January 27, 2026
From
Gilead Sciences, Inc.
Via
Business Wire
Gilead Sciences Inc. (NASDAQ:GILD) Passes the Caviar Cruise Quality Investing Screen
↗
January 22, 2026
Via
Chartmill
Demystifying Gilead Sciences: Insights From 17 Analyst Reviews
↗
January 27, 2026
Via
Benzinga
Exploring the top movers within the S&P500 index during today's session.
↗
January 23, 2026
Via
Chartmill
Here's How Much $1000 Invested In Gilead Sciences 15 Years Ago Would Be Worth Today
↗
January 22, 2026
Via
Benzinga
New England Journal of Medicine Publishes Phase 3 ASCENT-04/KEYNOTE-D19 Results Supporting Trodelvy® Plus Keytruda® as a Potential New Standard of Care in First-line PD-L1+ Metastatic Triple-negative Breast Cancer
January 21, 2026
From
Gilead Sciences, Inc.
Via
Business Wire
GILEAD SCIENCES INC (NASDAQ:GILD): A High-Yield, Low-Payout Dividend Stock for Disciplined Investors
↗
January 20, 2026
Via
Chartmill
Gilead Sciences Earnings Preview: What to Expect
January 19, 2026
Via
Barchart.com
Topics
Artificial Intelligence
ETFs
Government
Looking Into Gilead Sciences Inc's Recent Short Interest
↗
January 16, 2026
Via
Benzinga
A New Era in Rare Hepatology: The Deep-Dive Analysis of Mirum Pharmaceuticals (MIRM)
January 13, 2026
Via
PredictStreet
Topics
Economy
Initial Public Offering
J&J Cuts Deal With Trump’s White House To Slash Drug Prices And Dodge Tariffs
↗
January 08, 2026
Via
Stocktwits
Topics
Government
The 2026 Pharma M&A Outlook: Obesity, HIV, and the Biotech Renaissance
January 07, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
Gilead Sciences (GILD): Buy, Sell, or Hold Post Q3 Earnings?
January 05, 2026
Via
StockStory
Topics
Stocks
U.S. Scales Back The Number Of Vaccines It Recommends For Every Child
↗
January 05, 2026
Via
Stocktwits
Topics
Government
3 Cash-Flow Machines Investors May Want Heading Into 2026
↗
January 02, 2026
Via
MarketBeat
Here's How Much $1000 Invested In Gilead Sciences 15 Years Ago Would Be Worth Today
↗
January 01, 2026
Via
Benzinga
Biotech’s Resurgence: How a Year-End Rally and M&A Frenzy Set the Stage for 2026
December 31, 2025
Via
MarketMinute
Topics
Artificial Intelligence
ETFs
Economy
The Great Rebalancing: As Consumer Confidence Falters, Investors Retreat to the Safety of Large-Cap Value
December 31, 2025
Via
MarketMinute
Topics
Artificial Intelligence
ETFs
Economy
What's Driving the Market Sentiment Around Gilead Sciences Inc?
↗
December 31, 2025
Via
Benzinga
Stock Index Futures Slip in Weak End to a Banner Year
December 31, 2025
Via
Barchart.com
Topics
Bonds
Government
Stocks
Discover which S&P500 stocks are making waves on Tuesday.
↗
December 30, 2025
Via
Chartmill
GILEAD SCIENCES INC (NASDAQ:GILD) Shows High Technical and Setup Ratings for a Potential Breakout
↗
December 27, 2025
Via
Chartmill
Frequently Asked Questions
Is Gilead Sciences publicly traded?
Yes, Gilead Sciences is publicly traded.
What exchange does Gilead Sciences trade on?
Gilead Sciences trades on the Nasdaq Stock Market
What is the ticker symbol for Gilead Sciences?
The ticker symbol for Gilead Sciences is GILD on the Nasdaq Stock Market
What is the current price of Gilead Sciences?
The current price of Gilead Sciences is 141.95
When was Gilead Sciences last traded?
The last trade of Gilead Sciences was at 01/30/26 04:00 PM ET
What is the market capitalization of Gilead Sciences?
The market capitalization of Gilead Sciences is 177.98B
How many shares of Gilead Sciences are outstanding?
Gilead Sciences has 178B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.